Trial Profile

A Multi-center, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects With Chronic Non-infectious Uveitis Affecting the Posterior Segment of the Eye

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 23 Feb 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Fluocinolone acetonide (Primary)
Indications Posterior uveitis
Focus Registrational; Therapeutic Use
Sponsors EyePoint Pharmaceuticals

Most Recent Events

16 Nov 2020 Results presented in an EyePoint Pharmaceuticals media release.
16 Nov 2020 According to an EyePoint Pharmaceuticals media release, data from this trial were presented at American Academy of Ophthalmology (AAO) 2020 Virtual Annual Meeting.
10 Nov 2020 According to an EyePoint Pharmaceuticals media release, data from this trial will be presented at American Academy of Ophthalmology (AAO) 2020 Virtual Annual Meeting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com